Kentucky 2024 Regular Session Status: In Committee Bipartisan · 12 R · 1 D cosponsors

HB 490 — AN ACT relating to pharmaceutical drug price discrimination.

Last action — reassigned to Appropriations & Revenue (H)

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.

Bill Text

Action History

  1. reassigned to Appropriations & Revenue (H)

  2. to Health Services (H)

  3. to Committee on Committees (H)

  4. introduced in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

16 sponsors · 0 co-sponsors · 122 not signed on

Sponsors (16)

Co-sponsors (0)

None.

Not signed on (122)

122 members have not signed on to this bill.

Show all 122 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 490 do?
Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.
Who sponsors HB 490?
HB 490 is sponsored by Wade Williams (Republican), D. Bentley, John Blanton (Republican), Josh Bray (Republican), Chris Fugate (Republican), DJ Johnson (Republican), William Lawrence (Republican), Scott Lewis (Republican), Amy Neighbors (Republican), R. Palumbo, Steve Riley (Republican), Rachel Roarx (Democrat), Walker Thomas (Republican), K. Timoney, Timmy Truett (Republican), and Richard White (Republican).
What is the current status of HB 490?
This bill died with 2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 490?
Track HB 490 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 490

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 490

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →